AMH three-lens brief
Evidence-based stock research on AMH. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.11% yesterday. · Trading >3% below the 50-day MA — short-term weakness.
- Moved -2.11% yesterday.
- Trading >3% below the 50-day MA — short-term weakness.
- RSI at 27 — technically oversold.
- Underperforming SPY by 10.3pp over 30 days.
- Analyst mean target $37.20 — 18% above current (22 analysts).
AMH closed at $31.56 (-2.11%) as of 2026-09-11. Market cap: $12.94B. P/E (trailing) 25.7. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $37.20 — 18% above current (22 analysts).. Concerns: moved -2.11% yesterday.; trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $470.10M, net income $113.63M, free cash flow $822.33M.
Why three lenses on AMH, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMHacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMH" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMH brief"></iframe>